La dernière actualité médicale HaemophiliaXPERT Consultez la version en ligne Chère consœur, cher confrère, Retrouvez ci-après les dernières publications scientifiques issues de revues à comité de lecture dans votre domaine d'expertise. Publications du Mardi 21 juillet 2026 Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound Haemophilia (2026). Early identification of synovial hypertrophy is critical for preventing irreversible changes in haemophilic arthropathy (HA). Although prophylaxis has improved joint outcomes, it remains unclear which... En savoir plus |  Version PDF  |  Imprimer l'abstract Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A Molecular Medicine (June 2026) Among F8 mutation types, main determinants of inhibitor development after replacement therapy in Hemophilia A (HA), nonsense mutations display wide variation in the associated risk. Translational... En savoir plus |  Version PDF  |  Imprimer l'abstract INCREASED GENE THERAPY EFFICACY THROUGH THE USE OF EXTENDED HALF-LIFE CLOTTING FACTORS Blood advances (July 2026) of multiple clinical trials show significant interpatient variability in clinical outcomes, with a fraction of patients (up to 13%) even returning to prophylaxis. Another major challenge in current AAV... En savoir plus |  Version PDF  |  Imprimer l'abstract Effectiveness and Safety of Prophylactic Low-Dose Emicizumab in Young Children With Hemophilia A: A Multicenter Retrospective Study eJHaem (2026). Real-world data on low-dose emicizumab in young children with hemophilia A are limited. Methods: This multicenter retrospective study included 26 children (median age: 2.2 years) receiving individualized... En savoir plus |  Version PDF  |  Imprimer l'abstract Accueil  |  Actualités  |  Archives Informer un confrère | Modifier votre profil | Se désinscrire | Sources et critères Copyright 2026 © GNM Healthcare Group Companies USA, Inc.